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Introduction
Versatile analysers capable of measuring serum constituents
by different principles are gaining increasing popularity in
the clinical laboratory. To compete with or complement
large multichannel instruments, they must be efficient in
terms of running costs, labour costs and speed as well as
producing accurate and precise results. The Vitatron
programmable analyser (PA800) was evaluated using methods
for frequently requested analyses, aspartate transaminase
(AST), total bilirubin, cholesterol and glucose as well as for
the measurement of phenytoin by the EMIT* technique.
The methods were chosen to permit the instrument to display
its versatility regarding measuring principles. The evaluation
was carried out for the Department of Health and Social
Security and the protocol was based on the recommendations
of Broughton et al[ 1].
The Vitatron PA800
The instrument is the successor to the Vitatron Automatic
Kinetic Enzyme System (AKES), a discrete analyser,
evaluation reports of which have been published elsewhere
[2,3]. In addition to performing kinetic analysis of both
enzymes and substrates, the new instrument can also perform
endpoint analysis. In addition, the computer is capable of
curve fitting which increases the range of analyses which can
be performed by the instrument. Externally, the PA800
looks very similar to the AKES but there are several
differences in its mode of operation. The principle of the
transport mechanism, the movement of coded sample holders
in a chain through the system synchronised to the rotation of
a ring of eighteen thermostatted glass cuvettes through the
dispensing points and the lightpath, is unaltered. However,
whereas the coded sample holders for the AKES were supplied
in chains of ten those for the PA800 are supplied
individually. Unnecessary sample holders are not put through
the system which improves the instrument efficiency.
The PA800 uses reagents economically, they are sampled
from a compartmentalised reagent tray through stainless
steel probes in the sampling head by a water-filled
syringe system. The disposable reagent trays have two com-
partments, a smaller inner compartment for ’starter’ reagent
and a large one for the diluent reagent. For use, the tray is
sited adjacent to the cuvette ring. Three separate probes,
*EMIT is a registered trademark of the Syva Corporation.
one each for sample, diluent and starter, are incorporated
into the sampling head. Cleaning solution can also be dis-
pensed from each probe into the cuvetteS and, allows three
cuvette washes between analyses and as a vibrating mixer for
the cuvette contents (when reagent or sample are dispensed
into a cuvette). Volumes picked up and dispensed through the
probes are selected manually by means of micrometer
screws on Hamilton syringes. A stainless steel suction tube,
positioned in the sampling head, removes the cell contents,
under vaccuum, to a waste unit sited behind the sampling
head. The photometer has a quartz-iodine lamp and the
wavelength is selected by means of interference filters. Two
integrators are built into the photometer. During the
measurement of absorbance changes, ie whilst one inte-
grator is performing an integration, the other is transferring
the results of the previous integration to the calculator.
The system of audio and visual warnings used in the
AKES has been incorporated into the PA800, the audible
warning drawing attention to the instrument and the warning
lamps directing the operator to the source of the problem. In
addition, a temperature warning lamp is illuminated if the
cuvette ring is not at the programmed temperature.
The analytical process is controlled by the Canon Canola
SX- III calculator, which is an integral part of the system. In-
structions are fed into the calculator via magnetic cards.
Two general program cards are fed in daily. One or more
method cards, containing instructions specific for the assay
to be performed, including temperature of assay, incubation
times, number of measuring points and mode of calculation,
are fed in before performing an assay. Information and results
are printed on a tally roll. When a method program card has
been loaded, the syringe settings and interference filter
required are printed by the calculator and adjustments are
made manually. Alteration of the diaphragm position on the
photometer is also performed manually, but blanking is
carried out automatically by the instrument.
The mathematical analysis of the absorbance data for
kinetic measurements on the PA800 is more sophisticated
than that on the AKES. The photometer integrates the
absorbance change over consecutive intervals of 0.287
seconds, the number of readings being programmed for the
method in question. These measuring points are divided into
four blocks and the sum of integrations within each block is
calculated. After the monitoring period, the slope of the line
is calculated at two points during the time course of the
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reaction, using the absorbance changes in all four blocks for
calculation. The overall slope is computed from these figures
and the result calculated from this. In the case of enzyme
activity analysis, the two slope measurements are compared
to give a percentage deviation from linearity, which is printed
alongside the result.
For the endpoint measurements, the mean final absorbance
value is calculated from the readings taken at 0.287 second
intervals. This is done initially for each of the eighteen
cuvettes to give individual cuvette blank readings, which are
stored by the computer and subtracted appropriately from
all the subsequent absorbance readings, along with the
reagent blank value, which is derived from three aliquots of
reagent. The mean absorbance values for three aliquots of
the same standard serum are measured and used to compute
the factor necessary for result calculation. There is an alter-
native facility where this factor is pre-programmed into the
computer, obviating the need to put standards through with
each batch. Where sample blanks are required, the sera are
run through the instrument with suitable diluent prior to the
run with reagents, the blank readings being stored by the
computer for subtraction from the final result.
For the calculation of results forEMIT analyses, a response
is calculated for each sample or standard, relative to the
absorbance change measured for the zero standard. Several
standards are put through the system and the calculator
processes the responses to give a log-legit equation. The
sample results are calculated from this equation. For
thyroxine measurement by the EMIT technique, a modified
Gauss-Newton process is used for curve-fitting. For turbidi-
metric analyses, at least three standards of different
concentration are processed by the instrument and the
constants for the curve equation are derived by the computer.
We have used a kit for IgG measurement, manufactured by
the Boehringer Corporation, which is supplied with only
three standards, and have obtained satisfactory results using
the PA800. However, where possible, more than three
standards should be processed to define the standard curve
more clearly.
An optional extra component of the system is a Vitatron
2001 series recorder on which the photometer output is
expressed graphically. This provides valuable additional
information, particularly for enzyme activity measurements
where there are problems with the chemistry of the reaction,
such as unacceptable deviation from linearity or substrate
exhaustion.
Materials and methods
The evaluation was carded out over a 4 month period. Four
methods were examined in detail by the following
procedures.
(a) Precision A 20-day precision study, involving the analysis
of 20 aliquots of each of three quality control sera with
different concentrations of the constituent in question on
each of the 20 days, was carried out.
(b) Accuracy The main assessment of accuracy was by com-
parison of results obtained using the PA800 on at least 200
samples with those obtained using methods in routine use
in this laboratory. Analysis of commercially prepared quality
control sera with assigned values for the constituents studied
was also performed.
(c) Linearity Two samples, one of high concentration and
one of low concentration were combined to give samples
with a range of concentration which were analysed and the
results compared with the expected values.
(d) ’Carryover’ Studies to assess the contribution of ’carry-
over’ to results were carried out by repeated analysis of
alternate high and low concentration samples in triplicate, as
described by Young and Gochman [4].
The methodologies studied with this protocol and those
used for comparative purposes were as follows:
Aspartate transarninase This was measured according to the
Table 1. Alteration of temperature setting
Initial Temperature Final Temperature Time taken to achieve
setting C. setting C. new setting (mins.)
22.7 30.0 3.9
(Room Temperature)
25.0 30.0 2.4
25.0 37.0 5.8
30.0 25.0 3.6
30.0 37.0 3.7
37.0 25.0 6.4
37.0 30.0 3.2
Table 2. Assay costs and rate of analysis
Rate of Cost per Mode of Analysis Test Assay analysis (per hour) (p.)
Kinetic 144 1.7 Aspartate
transaminase
Total Endpoint 65 2.4
bilirubin with
serum blank
Cholesterol Kinetic 120 15.5
Glucose Kinetic 180 0.1
with
’Starter’
Cholesterol Endpoint 90 11.0
Phenytoin Curve 144 72.6
Analysis
recommendations of the Committee on Enzymes of the
Scandinavian Society for Clinical Biochemistry and Clinical
Physiology [5] and the assay was compared with the same
method performed on the Vitatron AKES. On both
instruments, the reaction took place at 37C and was
monitored at 340 nm. Reagents were manufactured by J. T.
Baker Chemicals, Deventer, Holland and supplied by Diamed
Diagnostics, Merseyside, U.K.
Total bilirubin Plasma bilirubifl was measured by the method
of Jendrassik [6], by endpoint analcsis with serum blank
correction, using a temperature of 37vC and a wavelength of
546 rim. Reagents were supplied by the Boehringer
Corporation (London) Ltd. For comparative purposes, bili-
rubin was measured according to the method of Michaelsson
7 and the recommendations of Billing, Haslam and Wald 8 ].
Cholesterol Plasma cholesterol was measured by kinetic sub-
strate analysis, without a starter reagent, using a cholesterol
oxidase method. The hydrogen peroxide produced oxidises
methanol to formaldehyde which reacts with ammonium
ions and acetylacetone to produce a dihydrolutidine derivative
which absorbs at 410 nm [9]. The assay was performed at
37C. Reagents were supplied by the Boehringer Corporation.
The method was compared to another cholesterol oxidase
method, using Trinder’s chromogen system 10], performed
on the Vickers M300 multichannel analyser 11 ].
Glucose Plasma glucose was measured by kinetic substrate
analysis with a starter reagent, using glucose oxidase cleavage
with the Trinder chromogen system [10]. The colour was
measured at 546 nm and the assay performed at 25C.
Reagents were supplied by the Boehringer Corporation. For
comparative purposes, glucose was measured on fluoridised
plasma samples by the glucose analyser, model 23AM of
the Yellow Springs Instrument Co. Ltd., which measures
electrochemically the hydrogen peroxide produced from
glucose by the action of immobilised glucose oxidase. This
instrument operates at 37C.
Less extensive studies were performed on two further
methods:
Cholesterol A cholesterol oxidase method, using endpoint
analysis, was examined. The hydrogen peroxide produced
converts iodide to iodine, which is measured photometrically
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at 356 nm. The reagents were manufactured by E. Merck,
Darmstadt, Federal Republic of Germany and supplied by
BDH Chemicals, Peele, U.K. Comparative studies were
carried out using the Vickers M300 method described above
[11].
Phenytoin Phenytoin was measured using the EMIT technique
[12] with reagents supplied by Syva Diagnostics (UK) Ltd,
Maidenhead. The reaction was monitored at 340 nm and
performed at 30C. A 4 #1 sample of neat serum was added
to a diluent solution comprising the enzyme-labelled drug in
a Tris-HC1 buffer. The reaction was initiated, prior to
monitoring, with a concentrated solution containing anti-
body to the drug, enzyme, s-ubstrate and coenzyme (NAD).
Quality control sera used for the study were supplied by
the Boehringer Corporation, Wellcome Reagents Ltd,
London, and BDH Chemicals.
Results and discussion
The PA800 is simple to use and economical on labour.
The instrument can be run efficiently by one operator who
can be usefully employed preparing reagents and samples for
the subsequent assay or processing results from the previous
assay while the instrument is in operation. The changeover
time from one assay to another is minimal, the rate-limiting
factor being the time taken for the cuvette ring to achieve
the programmed temperature (Table 1). The speed of assay
depends on the particular methodology with a maximum of
180 and an average of 120 samples being processed per hour
(Table 2). The cost per test, assuming a batch size of 50
samples, is shown in Table 2. These costs are reasonable and
although the phenytoin cost appears high, it is only 70% of
using the technique manually.
The performance of assays on the instrument depends on
the accuracy and reproducibility of instrumental com-
ponents. The temperature control and syringe precision were
studied as well as several features of the photometer.
Temperature control
External temperature measurements were made with a
Digitherm Mark II digital thermometer, manufactured by
Kane May (Barrow Field, Welwyn Garden City, Herts, U.K.),
which was inserted into the heating block surrounding the
cuvettes for readings to be taken. The time taken to achieve
the set temperature after re-programming the instrument was
measured in this way (Table 1), as was the temperature
stability at the three set temperatures (Table 3). It was not
possible, to assess the accuracy of the thermostat by this
method, since the accuracy of the thermometer was un-
known. A temperature sensor is fitted into the instrument
and the calculator can be instructed to print the temperature
at any time. Vitatron claim that this sensor is extremely
accurate and the temperature printed is the true temperature
of the cuvette ring. Using this facility no temperature drift
was observed during assays.
Syringe precision
No satisfactory way could be found to test the precision of
the syringes individually because the overall precision of the
sampling and dispensing system depends on the mixing and
cleaning features which do not function unless the instrument
is in operation. Consequently, the syringe combinations of
’Diluent-syringe with Starter syringe’ and ’Diluent syringe
with Sample syringe’ were tested using solutions ofpotassium
dichromate in 0.01N H2SO4 as the ’starter’ or ’sample’
respectively and 0.01N H2SO4 as diluent. Several com-
binations of volumes were examined, the concentration of
the potassium dichromate solutions being adjusted to give a
final cuvette concentration of 0.01 g/100ml. The absorbances
of the resultant solutions were in the order of 1.00 and were
measured at 366 nm. Using an arbitrary figure as the standard
value and an endpoint programme, it was possible to obtain
values from which the syringe precisions could be calculated.
The results are shown in Table 4 and are satisfactory. Studies
outside the evaluation, using smaller volumes down to a
4 #1 sample size, which is used for several methods on the
instrument, have shown the precision (CV%) to be in the
order of 1.5.
Photometer studies
Filter characteristics: Five filters supplied with the
instrument were examined using an SP1800 recording
spectrophotometer. Each filter was scanned between 200 and
600 nm and the wavelength at which the maximum trans-
mission occurred was noted. The half-band width was
calculated for this peak. It was ascertained that only one
transmission peak was present for each filter. Results for the
filter studies are shown in Table 5. The spectral quality of
the filters was satisfactory although the half-band width of
the 340 and 360 nm filters were marginally outside the
specifications of the manufacturer (8 12 nm).
Precision: The precision of the photometer was studied at
366 nm by taking multiple absorbance readings of potassium
Table 3. Temperature stability
Temperature 25C 30C 37C setting
No of
digitherm readings 11
(at minute intervals)
Mean
digitherm 26.40
reading
SD 0.05
CV% 0.18
11 11
31.08
0.06
0.19
Table 4. Syringe precision
Diluent Starter
syringe syringe
volume volume
Sample
syringe
volume
Mean
Reading SD
700 10
600 50
600 100
700
600
10
100
40
40
40
40
31
151.37
149.09
149.67
100.38
102.16
0.881
1.097
0.84
1.305
0.479
38.31
0.03
0.08
CV
%
0.58
0.74
0.56
1.30
0.47
Table 5. Filter studies
Assigned wavelength
of filter
nm.
Wavelength at
maximum transmission Half bandwidth
am. am.
340
366
405
490
546
340 12.8
366 12.5
406 10.5
491 9.0
544 10.0
Table 6. Photometer precision
K2Cr207 Mean
concentration N absorbance
rng/1 reading
SD CV %
250 10 1.984
190 10 1.573
125 20 1.022
94 20 0.760
62.5 20 0.489
31.3 20 0.251
15.7 20 0.125
10.4 20 0.081
0.006 0.29
0.005 0.32
0.002 0.25
0.003 0.36
0.002 0.51
0.003 1.08
0.001 0.91
0.002 2.12
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Table 7. Within-batch precision
Serum
constituent
Aspartate
transaminase U[ 1
Bilirubin
t/mol/1
Cholesterol
mmol/1
Glucose
mmol/1
Level
Low
Medium
High
Low
Medium
High
Low
Medium
High
Low
Medium
dichromate solutions with a range of concentration. The
precision of the absorbance values throughout the range
studied was satisfactory (Table 6).
Linearity: The linearity of the photometer response was
studied with a potassium dichromate solution at 366 nm, a
nickel sulphate solution at 405 nm and a cobalt nitrate
solution at 546 nm. The response was found to be linear at
the three wavelengths, all measured absorbances falling dose
to their expected values. The authors were particularly
impressed with the linearity at very low absorbance values
(Figure 1).
Methodological studies
Precision
Grand
mean
22.52
49.10
167.06
3.47
19.42
74.46
2.69
5.96
8.82
2.53
’6.05
12.00 The results of the 20-day precision study are shown in Tables High
7 and 8. The final values obtained for the coefficients of
variation for all methods were acceptable.
It will be noted that the between-batch coefficients of
variation for cholesterol, measured kinetically, and glucose
are closer in magnitude to the within-batch figures than
might be expected. The authors were disappointed with the
within-batch precision figures achieved during the 20-day
study and obtain much lower figures during routine operation
of the instrument. The precision figures we obtain between-
batch are similar to those the authors found during the 20-
day period. Our data suggests that the unexpectedly high
coefficient of variation figures found within-batch reflect
relatively poor precision on one or two days during the 20-
day study.As the mean value for the concentration of the
constituents on those days was not siginificantly different
from the overall mean, such imprecision does not affect
the between-batch figures.
The precision figures for the endpoint cholesterol method
re shown in Table 9. The CV% values found in both ithin-
batch and between-batch studies are better than those found
with the kinetic cholesterol method but it should be noted
that the endpoint method was not subjected to such a
rigorous precision study and was studied when the operator
had gained considerable experience with the instrument.
The endpoint method was preferred because the reagent
preparation was easier and because it was cheaper (Table 1).
The precision figures for the other kinetic method studied,
glucose, are better than those for cholesterol probably
because the reaction is much faster and the absorbance
changes being measured are greater, the reaction being
initiated with a starter reagent just before the monitoring
position. A kinetic uric acid method is routinely used on the
instrument in which uricase is added as the starter reagent,
this performs completely satisfactorily. It is recommended
that where substrate measurement is being contemplated on
Absorbance
0.i0
0.08
0.06
0.04
Expected Values /
i0 mg/l
0.02
Table 8. Between-batch precision
Serum
constituent
Aspartate
transaminase U/1
Bilirubin
tanol/1
Cholesterol
mmol/1
Glucose
mmol/1
Level
LOW
Medium
Low
Medium
High
Low
Medium
High
Low
Medium
High
Figure 1. Photometer Linearity 366nm
Mean of
SD
0.87
1.15
2.10
0.32
0.77
2.14
0.20
0.26
0.38
0.12
0.14
0.25
Mean of
CV%
3.80
2.33
1.24
9.70
3.87
2.89
7.19
4.40
4.26
5.08
2.27
2.06
Grand SD’oday
mean means
22.52
49.10
167.06
3.47
19.42
74.46
2.69
5.96
8.82
2.53
6.05
12.00
1.85
2.33
4.21
0.53
1.43
4.22
0.17
0.28
0.40
0.12
0.14
0.34
CV %
8.22
4.74
2.52
15.32
7.35
5.66
6.17
4.68
4.51
4.63
2.33
2.84
Table 9. Cholesterol (endpoint) precision study
Within-batch
Between-batch
Mean Sample N mmol/1
Serum A 20 2.765
Serum B 20 5.490
SerumC 20 6.835
Precilip 21 3.429
Seronorm
lipid 20 6.180
Precilip 20 7.480 EL
SD
mmol/1
0.049
0.079
0.093
0.085
0.144
0.104
1.77
1.44
1.37
2.47
2.32
1.39
/
1.26
100 140 U/1
Figure 2. Accuracy: Aspartate Transaminase
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the PA800, an endpoint method or a kinetic method which
is fast and utilises a starter reagent, should be chosen.
Precision figures for the phenytoin assay are shown in Table
10. These were calculated by statistical analysis of the results
obtained on duplicate samples assayed in the same batch for
within-batch figures and in different batches for between-
batch figures. The CV% values are far better than those
generally accepted for immunoassay techniques.
Accuracy
Results of the comparative studies with alternative methods
are shown in Figures 2 6 and results obtained on quality
control sera are shown in Table 11. The authors were pleased
with the performance of all assays with respect to accuracy,
the correlation coefficients being above 0.99 for all methods
except the kinetic measurement of cholesterol. Results
obtained from the glucose assay were lower than those
obtained by the Yellow Springs Glucose analyser. Results
obtained on a continuous flow-system using the Trinder
method are lower than those measured on the Yellow Springs
instrument and presumably this is a feature of the different
principles of measurement. It will be noted that results from
the endpoint cholesterol method are lower than those
obtained on the_ Vickers M300 (Figure 6). This method is
one for which a pre-programmed factor for result calculation
is employed and we found all results to be too low as judged
by the comparative method and by values obtained on
quality control sera with assigned values. Subsequently the
factor was changed from 8.15 to 9.0 and this led to much
better agreement with alternative methods. The results in
Table for this method were obtained after the factor had
been altered. The other endpoint method studied, bilirubin,
was also found to be inaccurate using the programmed factor
and this was changed from 146 to 175 to produce acceptable
results. The factor of 175 was used throughout the evaluation
period. It is recommended that where possible, serum
standards are analysed with endpoint assays, allowing the
factor to be calculated for each run of samples.
Linearity
The results of the linearity studies are shown in Table 12. All
methods were linear throughout the ranges studied which in
all cases extended to pathological levels. Comparative studies
using patient samples have shown that the bilirubin and the
kinetic cholesterol methods are not linear above 200/amol/1
and 10mmol/1 respectively.
PAS00 mol/l
60 203
y 0.950x 0.395
30 ./o .j,
o ’/r’- "2.. .,: :.
Fibre 3. Accuracy: Bilibin
umol/l
Michaelson
Carryover
The figures obtained for mean percentage interaction (1%)
for the methods studied were:- aspartate transaminase 0.0,
bilirubin 0.11, cholesterol 0.94 and glucose 0.10. These are
all well below the maximum recommended figure of 2% [4],
as would be expected with the discrete sampling mechanism
and adequate washing of the sample probe.
Apart from the problems with pre-programmed factors
mentioned earlier, all the kinetic and endpoint methods
studied functioned well on the PA800 when the recommen-
dations of the instrument manufacturer were followed.
However problems were found with the EMIT Phenytoin
assay and the method had to be modified before acceptable
results were produced. The reagent preparation was altered
such that the NAD was in the starter reagent, not the diluent
solution, in which it was unstable.
Table 10. Phenytoin precision study
Within-batch
Between baich
No.
20
28
Range Of
Values
/ag/ml
Mean
Value
pg/100ml
SD CV
pg/lOOml %
0.9-33.5 11.86 0.523
0.- 36.’8" 10.84 0.367
Table 11. Accuracy control sera studies
Assay
Aspartate
rransaminase
U/1
Bilirubin
Ltmol/1
Cholesterol
(Kinetic)
mmol/1
Glucose
mmol/1
Cholesterol
Iendpoint)
mmol/1
Phenytoin
Material No. of Mean Assigned
used analyses result value
Wellcomtrol BC02 21 162 167
Precinorm U 7 58 60
Precipath E 4 138 142
Wellcomtrol BC02 16 89.5 88
Pricinorm U 18 20 23
Precilip 9 3.8 3.2
Precilip E.L. 6 8.2 7.5
Wellcomtrol BC02 18 10.9 11.8
Wellcomtrol BC03 15 1.9 3.1
Precilip 21 3.4 3.2
Seronorm Lipid 20 6.2 6.5
Pricilip E.L. 20 7.5 7.5
Wellcomtrol BC03 15 12.9 12.6
PAS00 mmol/l
14.0. 1.063x 0.183 /
0.952
lO.O. #:o
; .. "’’
4.0 .."
2.0 40 6.0 8.0 10.0 12.0 14.0 (1/1)
(Vickers M300
Figure 4. Accuracy: Cholesterol (Kinetic)
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The criticisms of design made in the report on the AKES
[2] have largely been overcome on the PA800. Although
there is still no choice in the position at which starter reagent
can be added, the improved method of calculation of enzyme
activity ensures that, should a reaction be initiated by serum
as for creatine phosphokinase measurement, the incubation
times for all cuvettes are identical, which was not the case
on the AKES. Similarly, where a starter reagent is used, the
incubation period with starter, before the reaction is
monitored, is identical for all cuvettes. The programmable
calculator gives flexibility ie incubation times and pro-
gramme changes can be effected simply by the operator.
A fast transport mechanism has been incorporated into the
instrument so that, if required, a chain of sample holders can
be removed rapidly from the system. A modification has
been made to the cuvette ring. The cuvettes in the PA800
are detachable from their mounting so that should one need
to be replaced, it can be changed easily by the operator.
Formerly, the cuvettes were fixed in their mounting and
damage to one cuvette necessitated returning the complete
ring to the manufacturer for repair.
The authors have some minor criticisms of the instrument.
Firstly, the silicone tubing which carries the cuvette contents
to the waste unit is directed around the back of the sampling
head and great care must be exercised when lowering the
sampling head into position to prevent the tubing being
trapped. Secondly, when a leak occurs in a part of the system
not immediately visible, there is no alarm and the presence of
the leak is not made obvious. This is a particular problem if
tubing became detached inside the master value unit or
inside the base of the waste unit.
Table 12. Linearity studies
%Ain
specimen
0
20
40
60
8O
100
Aspartate transaminase
o/1
Expected Observed
concentration concentration
26.5
53.7
80.9
108.1
135.3
162.5
53.3
8O.O
107.3
134.0
Bilirubin
Nmol/1
Several faults occurred on the instrument used during the
first six months it was in the laboratory. All were rectified
promptly by the service engineer. The most worrying fault
concerned the temperature control system and was eventually
traced to a faulty transistor. There was no warning of the
existence of this fault as the temperature warning light was
not illuminated, even though the cuvette ringhad not achieved
the programme temperature. Similary, when the ’temperature’
key on the calculator was depressed the programmed, not the
actual, temperature was printed. The problem has not
recurred since the transistor was replaced.
The instrument was supplied with a belt-driven sampling-
head mechanism, which failed on three occasions due to
breakage of the drive-belt and the instrument has since been
fitted with a spindle-driven mechanism, analagous to that on
the ’AKES. All new models are being supplied with this
mechanism and those already installed have been modified.
Three other minor faults were swiftly rectified. These were
caused by a defective drive belt on one of the mixing probes
such that it could not vibrate, a loose electrical connection
in the sampling head and a faulty flange in a tubing connec-
tion. The instrument was subjected to an electrical safety
examination and was found to comply with the Electrical
Safety Code for Hospital Laboratory Equipment.
No problems were experienced with the calculator which
greatly improves the efficiency of the analytical process.
In certain laboratory situations a larger computer would
be an advantage. If memory were to be increased, additional
versatility and improvements would be possible. For
example, absorbance readings could be stored until the end
of a run for scrutiny before result calculation. Long term
storage of data would allow results of several analyses on one
patient to be reported together, reducing the potential for
Expected Observed
31.85
63.03
93.63
131.38
1.80
34.09
66.38
98.67
130.96
163.25
Cholesterol
mmol/1
Expected Observed
1.55
3.03
4.50
5.98
7.45
8.93
3.05
4.48
6.15
7.48
Glucose
mmol/1
Expected
1.96
7.12
12.28
17.43
22.59
27.75
Observed
6.97
12.24
17.94
22.84
PAS00 nol/l
24.0
20.0
16.0
12.0
8.0
4.0
/
N 202 /
/
y 0.992x 0.829 /
.,/.
0.992
o o
4.0 8.0 12.0 16.0 20.0 24.0 mmol/l
Yellow Springs Glucose Analyser
Figure 5. Accuracy: Glucose
PA800 mmol/l
12.0
i0.0
8.0
6.0
4.0
2.0
N 109
y 0.922x 0.250
0.992
2.0 4.0 6.0 I0.0 12’.0 mmol/l
Vickers M300
Figure 6. Accuracy: Cholesterol (Endpoint)
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reporting errors. An increased computer facility would be
particularly useful for laboratories which do not have a
.sophisticated data-processing system. In its present form,
the output of the calculator can be fed directly into data
processing systems in current use in clinical biochemistry.
Conclusions
The Vitatron PA800 is a reliable instrument which produces
accurate results on small volumes of serum with minimum
wastage of reagents. It is equally suitable for the analysis of
large batches of samples for the more commonly requested
clinical analyses and for processing small numbers of samples,
whether for more specialised analyses or in a laboratory with
a small workload. This versatility should enable the instru-
ment to fulfil a useful role in most clinical laboratories.
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Description
The Chemispek is a multichannel analyser of the continuous
flow type with a microprocessor-based system for collection
and presentation of results. Modular in design, the equipment
is similar in many respects to the earlier Chromaspek amino
acid analyser produced by the same company (Rank Hilger,
Margate).
At present, up to twelve simultaneous channels may be
operated, chosen from a rang of seventeen chemistries.
An eight channel configuration was chosen as being most
suitable for the requirements of this department providing
the following analyses: sodium, potassium, chloride, carbon
dioxide, urea, creatinine, calcium and phosphate.
The instrument is supplied complete with a mounting
stand although the individual modules may be bench
mounted. The dimensions arc length, 2.5 m; depth 0.8 m
and height, 1.5 m. An additional stand carrying a chart
recorder and microprocessor measures 0.8 m in length, 0.8 m
in depth and m in height. There is also a free standing
matrix printer of similar dimensions to the smaller stand.
*Correspondence should be addressed to Dr. R.W. Logan, Consultant
Medical Biochemist at the above address.
The instrument is designed to be operated at sampling
speeds of up to 120/h depending upon the chemistries
involved. As no system of positive sample identification is
provided, it is necessary to record the exact sequence of
analysis of the specimens in the trays. The sampler module
provides for switch-selectable sampling rates covering a
wide range of settings. The sample to wash ratio is variable
and there is a facility to introduce an air bubble between
samples.
Reagents are distributed to each twin channel chemistry
module by means of four-speed peristaltic pumps. Wash
valves provide the means by which all or individual channels
may be switched to wash water. The frequency of air
injection to the flowing reagent stream may be altered by
thumbscrews mounted on the introduction blocks. The fast
speed setting of the pumps allows for rapid filling of the
system with reagent or fast wash out with water, while the
slowest pump speed setting allows the machine to be kept
in a state of readiness over long periods while using a mini-
mum of reagent.
Heating baths, dialysers, coils and connecting tubing are
mounted on removable plastic trays. Effluent is channelled
away through a series of interconnected drains which may be
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